What's breaking now, across thousands of outlets.
NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay
We haven't written up this one. The Hindu has the full story — the link below goes straight to it.
Israel holds recruitment drive for British doctors amid physician brain drain Submitted by Katherine Hearst on Wed, 10/28/2026 - 12:55 Leaflets listing medical centres in illegal settlements were…
(MedPage Today) -- For patients with advanced or metastatic solid tumors who had initial responses to immune checkpoint inhibitors (ICIs), reducing dose intensity did not preserve efficacy, an interim…
Many thanks to all the entrants of the October Research is Beautiful image competition – here is our worthy winner… The post Latest winner in our Research is Beautiful competition appeared first on…
Current and former leaders at the Centers for Medicare and Medicaid Services (CMS) on Wednesday advised Medicare beneficiaries to pay close attention to their options this year upon reenrolling in…
Long COVID is a phenomenon in which serious health effects linger well after a patient tests negative for coronavirus infection.
